chr6-51619550-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_138694.4(PKHD1):​c.11786-30C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.17 in 1,575,624 control chromosomes in the GnomAD database, including 24,270 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1908 hom., cov: 33)
Exomes 𝑓: 0.17 ( 22362 hom. )

Consequence

PKHD1
NM_138694.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0380

Publications

5 publications found
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
PKHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
  • polycystic kidney disease 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
  • Caroli disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 6-51619550-G-A is Benign according to our data. Variant chr6-51619550-G-A is described in ClinVar as Benign. ClinVar VariationId is 262386.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.344 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKHD1NM_138694.4 linkc.11786-30C>T intron_variant Intron 66 of 66 ENST00000371117.8 NP_619639.3 P08F94-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKHD1ENST00000371117.8 linkc.11786-30C>T intron_variant Intron 66 of 66 1 NM_138694.4 ENSP00000360158.3 P08F94-1
ENSG00000228689ENST00000454361.1 linkn.81-2805G>A intron_variant Intron 1 of 1 3
ENSG00000228689ENST00000589278.6 linkn.811-2810G>A intron_variant Intron 2 of 2 5
ENSG00000228689ENST00000650088.1 linkn.222-2805G>A intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.146
AC:
22195
AN:
152016
Hom.:
1908
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0762
Gnomad AMI
AF:
0.209
Gnomad AMR
AF:
0.117
Gnomad ASJ
AF:
0.153
Gnomad EAS
AF:
0.358
Gnomad SAS
AF:
0.222
Gnomad FIN
AF:
0.182
Gnomad MID
AF:
0.121
Gnomad NFE
AF:
0.167
Gnomad OTH
AF:
0.135
GnomAD2 exomes
AF:
0.176
AC:
43306
AN:
246564
AF XY:
0.179
show subpopulations
Gnomad AFR exome
AF:
0.0783
Gnomad AMR exome
AF:
0.104
Gnomad ASJ exome
AF:
0.156
Gnomad EAS exome
AF:
0.390
Gnomad FIN exome
AF:
0.183
Gnomad NFE exome
AF:
0.170
Gnomad OTH exome
AF:
0.149
GnomAD4 exome
AF:
0.173
AC:
245822
AN:
1423490
Hom.:
22362
Cov.:
25
AF XY:
0.174
AC XY:
123577
AN XY:
710710
show subpopulations
African (AFR)
AF:
0.0715
AC:
2344
AN:
32770
American (AMR)
AF:
0.105
AC:
4682
AN:
44640
Ashkenazi Jewish (ASJ)
AF:
0.157
AC:
4068
AN:
25876
East Asian (EAS)
AF:
0.324
AC:
12782
AN:
39480
South Asian (SAS)
AF:
0.200
AC:
17067
AN:
85268
European-Finnish (FIN)
AF:
0.178
AC:
9383
AN:
52834
Middle Eastern (MID)
AF:
0.135
AC:
773
AN:
5712
European-Non Finnish (NFE)
AF:
0.172
AC:
184985
AN:
1077902
Other (OTH)
AF:
0.165
AC:
9738
AN:
59008
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
9936
19873
29809
39746
49682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6578
13156
19734
26312
32890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.146
AC:
22199
AN:
152134
Hom.:
1908
Cov.:
33
AF XY:
0.149
AC XY:
11073
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.0762
AC:
3162
AN:
41514
American (AMR)
AF:
0.117
AC:
1788
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.153
AC:
529
AN:
3464
East Asian (EAS)
AF:
0.358
AC:
1852
AN:
5178
South Asian (SAS)
AF:
0.221
AC:
1065
AN:
4820
European-Finnish (FIN)
AF:
0.182
AC:
1923
AN:
10578
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
292
European-Non Finnish (NFE)
AF:
0.167
AC:
11371
AN:
67972
Other (OTH)
AF:
0.135
AC:
285
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
950
1900
2851
3801
4751
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
254
508
762
1016
1270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.157
Hom.:
6874
Bravo
AF:
0.141
Asia WGS
AF:
0.238
AC:
826
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive polycystic kidney disease Benign:1
Apr 12, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease 4 Benign:1
Jun 19, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.8
DANN
Benign
0.26
PhyloP100
0.038
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9395699; hg19: chr6-51484348; COSMIC: COSV64401020; COSMIC: COSV64401020; API